Old Web
English
Sign In
Acemap
>
authorDetail
>
Samantha DePadova
Samantha DePadova
Medicine
Immunology
Bristol-Myers
Internal medicine
Cohort
4
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TP53 Mutations Determine Outcome of Patients (pts) with High-Risk Myelodysplastic Syndrome (HRMDS) and Acute Myelogenous Leukemia (AML) Regardless of Karyotype and ELN Risk Stratification
2016
Blood
James McCloskey
Marshall McKenna
Jamie L. Koprivnikar
Samantha DePadova
Genique Stanislaus
Stuart L. Goldberg
Stefan Faderl
Show All
Source
Cite
Save
Citations (0)
Features and Outcome of Patients (Pts) with New Diagnosis of Acute Myeloid Leukemia (AML) with Monocytic Differentiation (AML-Mo) Following Standard Induction Therapy. Do We Need a Different Strategy?
2016
Blood
James K. McCloskey
Samantha DePadova
Jamie L. Koprivnikar
Tracy Andrews
Marshall McKenna
Genique Stanislaus
Stuart L. Goldberg
Stefan Faderl
Show All
Source
Cite
Save
Citations (0)
Outcome of Acute Myeloid Leukemia (AML) Induction Therapy Based on D14 Marrow Biopsy According to European Leukemia Net (ELN) Risk Classification
2016
Blood
David Ray
Jamie L. Koprivnikar
James K. McCloskey
Genique Stanislaus
Christina Howlett
Amy L. Davidow
Samantha DePadova
Stuart L. Goldberg
Stefan Faderl
Show All
Source
Cite
Save
Citations (0)
A Multidisciplinary Approach to Standardizing Processes for Blinatumomab Administration
2016
Clinical Journal of Oncology Nursing
Samantha DePadova
Christina Howlett
Kimberly Rivera
Show All
Source
Cite
Save
Citations (3)
1